跳至主要内容
临床试验/NL-OMON24082
NL-OMON24082尚未招募不适用

Impact of a cardiac rehabilitation program versus coronary revascularization in patients with stable coronary artery disease

Maxima Medisch Centrum0 个研究点目标入组 216 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
216

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • A diagnosis of SAP with residual angina symptoms after OMT
  • - Established ischemia (assessed by SPECT, PET, Stress ultrasound, CMR, or cycle ergometry)
  • - Access to a personal computer, laptop or tablet with Internet connectivity at home.
  • - Access to a mobile phone with short message service (SMS) functionality to login to the web application with two-factor authentication.

排除标准

  • An echocardiography and coronary angiography (usual care group) or coronary computed tomography (CT)-angiography (CR group) will be performed to exclude high-risk patients with a reduced left ventricular function (i.e. left ventricular ejection fraction <35%). After randomisation patients will also be screened for stenosis of the left main coronary artery through computed tomography (intervention group) or coronary angiogram (control group). For these patients previous work revealed the potential prognostic benefit of revascularization, in terms of mortality, also supported by latest guidelines on myocardial revascularization with a class 1A indication for revascularization.
  • Other exclusion criteria include:
  • 1.PCI or CABG in the past year
  • 2.Acute coronary syndrome in past 2 months
  • 3.Angina symptoms at rest or rapidly progressive (i.e. unstable angina)
  • 4.Ischemic threshold <50 watts
  • 5.New-York Heart Association class III-IV heart failure symptoms
  • 6.Advanced chronic kidney failure (i.e. estimated Glomerular Filtration rate <30ml/min)
  • 7.Severe ventricular arrhythmia or exercise-induced arrythmia at baseline testing
  • 8.A comorbidity precluding exercise training (e.g. orthopaedic, neurological or cognitive conditions) or other contra-indications for exercise training.

研究者

发起方
Maxima Medisch Centrum

相似试验